Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Juliane Schuhmacher"'
Autor:
Per thor Straten, Cécile Gouttefangeas, Juliane Schuhmacher, Sara Fresnillo Saló, Anne Rahbech, Sara Pedersen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ed6149746fdb49a6a9f92d00d3e6b54a
Autor:
Juliane Schuhmacher, Leon Kleemann, Jennifer Rebecca Richardson, Elisa Rusch, Hans-Georg Rammensee, Cécile Gouttefangeas
Publikováno v:
Cells, Vol 11, Iss 21, p 3451 (2022)
Elongated peptides (EPs), containing possibly one or multiple epitope/s, are increasingly used for the screening of antigen-specific CD8+ and CD4+ cell responses. Here, we present an in vitro protocol that allows the amplification of antigen-specific
Externí odkaz:
https://doaj.org/article/a0ef7cb660bb49469bb5c0e9cd19c84e
Autor:
Anna Schöllhorn, Juliane Schuhmacher, Luciana Besedovsky, Rolf Fendel, Anja T. R. Jensen, Stefan Stevanović, Tanja Lange, Hans-Georg Rammensee, Jan Born, Cécile Gouttefangeas, Stoyan Dimitrov
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
We have previously shown that conformational change in the β2-integrin is a very early activation marker that can be detected with fluorescent multimers of its ligand intercellular adhesion molecule (ICAM)-1 for rapid assessment of antigen-specific
Externí odkaz:
https://doaj.org/article/f3bcdb9d3d734854a12459d79a49a02e
Autor:
Juliane Schuhmacher, Sonja Heidu, Torben Balchen, Jennifer Rebecca Richardson, Camilla Schmeltz, Jesper Sonne, Jonas Schweiker
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Peptide-based vaccination is a rational option for immunotherapy of prostate cancer. In this first-in-man phase I/II study, we assessed the safety, tolerability and immunological impact of a synthetic long peptide vaccine targeting Ras hom
Externí odkaz:
https://doaj.org/article/1507b2f7b7b84a1892aad4dd5376925e
Publikováno v:
Cancers, Vol 13, Iss 4, p 596 (2021)
Cancer immunotherapy activates the immune system to specifically target malignant cells. Research has often focused on CD8+ cytotoxic T cells, as those have the capacity to eliminate tumor cells after specific recognition upon TCR-MHC class I interac
Externí odkaz:
https://doaj.org/article/dff6ab03f7924068ab966d0e5cc96f84
Publikováno v:
Seminars in Immunopathology. 45:203-214
Tumour cells do not exist as isolated entities. Instead, they are surrounded by a variety of cells and extracellular matrix, which form the tumour microenvironment (TME). The interaction between cancer cells and their microenvironment is increasingly
Autor:
Yacine Maringer, Annika Nelde, Sarah M. Schroeder, Juliane Schuhmacher, Sebastian Hörber, Andreas Peter, Julia Karbach, Elke Jäger, Juliane S. Walz
Publikováno v:
Science Immunology. 7
Several COVID-19 vaccines are approved to prevent severe disease outcome after SARS-CoV-2 infection. Whereas induction and functionality of antiviral antibody response are largely studied, the induction of T cells upon vaccination with the different
Publikováno v:
Cancer Immunol. Immunother. 68, 1855-1863 (2019)
Monitoring T cells is of major importance for the development of immunotherapies. Recent sophisticated assays can address particular aspects of the anti-tumor T-cell repertoire or support very large-scale immune screening for biomarker discovery. Rob
Autor:
Anna, Schöllhorn, Juliane, Schuhmacher, Luciana, Besedovsky, Rolf, Fendel, Anja T R, Jensen, Stefan, Stevanović, Tanja, Lange, Hans-Georg, Rammensee, Jan, Born, Cécile, Gouttefangeas, Stoyan, Dimitrov
Publikováno v:
Frontiers in Immunology
We have previously shown that conformational change in the β2-integrin is a very early activation marker that can be detected with fluorescent multimers of its ligand intercellular adhesion molecule (ICAM)-1 for rapid assessment of antigen-specific
Autor:
Tanja Lange, Stoyan Dimitrov, Rolf Fendel, Anja T. R. Jensen, Juliane Schuhmacher, Jan Born, Cécile Gouttefangeas, Hans-Georg Rammensee, Stefan Stevanovic, Luciana Besedovsky, Anna Schöllhorn
We have previously shown that beta2-integrin conformational change is a very early activation marker that can be detected with fluorescent multimers of its ligand ICAM-1 for a rapid assessment of antigen-specific CD8+ T cells. Here, we describe a mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7081293bda00ab9afb1ebadfcb393886
https://doi.org/10.21203/rs.3.rs-67111/v1
https://doi.org/10.21203/rs.3.rs-67111/v1